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A dynamic mixture of iron complexes was used as a colorimetric sensor for sulfated glycosaminoglycans.
The sensing ensemble was prepared by mixing [FeCl2(H2O)4] with dipicolylamine, the functionalized
bipyridyl ligand N-(6-aminohexyl)-4¢-methyl-2,2¢-bipyridine-4-carboxamide, and the dye Evans Blue.
Upon addition of the analytes, characteristic changes in the UV-Vis spectrum of the solutions were
observed. The spectral changes allowed identifying different sulfated glucosaminoglycans
(unfractionated heparin, low molecular weight heparin, dextran sulfate, chondroitin sulfate A,
dermatan sulfate, heparan sulfate) with the help of a linear discriminant analysis. Furthermore, it was
possible to distinguish mixtures of unfractionated heparin and heparan sulfate with good resolution.
Introduction
Heparin is a sulfated glycosaminoglycan, which is widely used
in the clinic as an anticoagulant and antithrombotic agent.1
In view of its pharmacological importance, it is not surprising
that considerable efforts have been made to develop methods
for the analysis of heparin.2 These methods are of interest for
the quantiﬁcation of heparin in biological samples (e.g. blood
serum) or for the quality control of pharmaceutical preparations.
The latter issue became particularly relevant after the discovery
that contaminated unfractionated heparin (UFH) had entered
the market, which resulted in the death of about 200 patients
worldwide.3
Colorimetric or ﬂuorescent chemosensors for heparin are
appealing because the required instruments are relatively cheap
and easy to access. In recent years, a number of such sensors
have been reported.4 In most cases, the goal was to rapidly
quantify heparin in blood. Since blood is a complex biological
matrix, it was desirable to develop a sensor with a very high
selectivity for the target heparin. For a chemosensor that is
used in quality control, however, a perfectly selective sensor
is not necessarily the best choice. On the contrary, it would
be interesting to have a sensor that is able to simultaneously
detect heparin and potential contaminants. The group of Nitz
has recently reported an interesting approach in this direction.5
They have demonstrated that an array of indicator displacement
assays (IDAs)6 was able to provide diagnostic patterns for several
sulfated polysaccharides. The individual IDAs of the sensor array
were obtained by mixing amine-functionalized cyclodextrins with
lithocholic acid derivatives containing a quinolinium ﬂuorophore.
In the following we describe an alternative approach to create a
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cross-reactive chemosensor for sulfated glycosaminoglycans. It is
shown that a dynamic mixture of Fe(II) complexes can be used to
differentiate sulfatedpolysaccharides byUV-Vis spectroscopy.The
assay allows the identiﬁcation of common glycosaminoglycans
with high ﬁdelity. Furthermore, it is possible to distinguish
mixtures of UFH and heparan sulfate with good resolution.
Results and discussion
We have recently demonstrated that dynamic mixtures of metal
complexes can be used as powerful colorimetric sensors.7 The
basic principle is shown in Scheme 1. A mixture of homo- and
heteroleptic metal complexes is formed upon addition of one or
more exchange-labile metal ions to a set of ligands. In order to
utilize such a mixture as a colorimetric sensor, several species
need to be colored. This can be achieved by using colored ligands
(e.g. metal-binding dyes) or ligands, which give colored metal-
complexes. If the addition of an analyte leads to a re-equilibration
of the system, a color change will be observed. A pattern-based
analysis of the spectral changes can then be used to obtain
information about the identity, the quantity, or the purity of the
analytes.
Scheme 1 A dynamic mixture of homo- and heteroleptic complexes is
formed by reaction of an exchange-labile metal ion (grey circle) with a
set of colored ligands. The addition of an analyte, which binds to one
or several species of the mixture, will result in a re-equilibration and a
characteristic change in color.
This journal is © The Royal Society of Chemistry 2010 Org. Biomol. Chem., 2010, 8, 2327–2331 | 2327
Sensors based on dynamic combinatorial libraries8,9 of metal
complexes have some interesting characteristics. First of all, it
is very easy to make the sensors because they are obtained by
mixing commercially available or easily accessible building blocks.
Secondly, the sensors can rapidly be optimized for a particular
sensing problem by variation of the nature and/or the quantity of
the metal ions and the ligands. A potential drawback, however, is
that these sensors are not very selective. The sensing of analytes
in a complex matrix containing interfering substances can thus be
problematic, unless variations of the matrix are small (constant
background). For the analysis of mixtures of analytes under
standardized conditions, however, these sensors are potentially
very well suited.
Our starting point for the development of a colorimetric
chemosensor for sulfated glycosaminoglycans was the recent
discovery that Ru(II) complexes with bipyridyl ligands containing
protonated amine side chains are able to bind to heparin in
buffered aqueous solution.4b We reasoned that by combining a
similar ligand with the exchange-labile Fe(II) instead of Ru(II) we
would be able to make a dynamic complex with an afﬁnity for
negatively charged, polysulfated sugars. Therefore, we synthesized
the amine-substituted bipy ligand 1 following a recently reported
procedure (Scheme 2).10 Subsequent reaction with [FeCl2(H2O)4]
in buffered aqueous solution gave the homoleptic complex
[Fe(1)3]n+ as evidenced by spectrophotometric titrations (seeESI†).
It is expected that the primary amine groups are protonated at
Scheme 2 Formation of the homoleptic complex [Fe(1)3]5+. The amine–
substituted bipy ligand 1 was synthesized from 4,4¢-dimethyl-bipyridine
as described in the literature:10 a) SeO2, dioxane; b) AgNO3/NaOH,
water–ethanol; c) CDI, DMF, Boc-NH(CH2)6NH2; d) HCl/methanol.
neutral pH. Therefore, the complex [Fe(1)3]n+ exists predominantly
as a pentacation under these conditions (n = 5).
For the creation of a dynamic mixture of Fe(II) complexes,
we decided to use two additional ligands: dipicolylamine (dpa)
and the dye Evans Blue. The tridentate ligand dpa is known to
form stable ML2 complexes with Fe(II).11 In aqueous solution,
[Fe(dpa)2]2+ shows a broad absorption band in theUV/Vis-spectra
with a maximum at 431 nm. The complex can thus easily be
distinguished from [Fe(1)3]n+, which shows a broad band with a
maximum at 540 nm.
The third ligand, Evans Blue (EB), was chosen because of
several favorable characteristics. Similar to dpa, the diazo dye EB
is commercially available. In aqueous solution, EB shows a strong
absorption at 606 nm, which is well separated from the absorption
maxima of the homoleptic complexes with the ligands dpa (lmax =
431 nm) and 1 (lmax = 540 nm). Furthermore, EB was found to
form heteroleptic complexes with [Fe(dpa)2]2+ and [Fe(1)3]5+. This
was evidenced by spectrophotometric titrations. When aliquots of
a stock solution of complex [Fe(1)3]5+ were added to a buffered
aqueous solution of EB ([EB] = 7.5 mM, MOPS, pH 7.0), the
band at 606 nm decreased with concomitant formation of a new
maximum at 556 nm (Fig. 1). The spectral changes level off at a
ratio of [Fe(1)3]5+:EB= 1 : 1. Assuming that EB acts as a bidentate
ligand and that Fe(II) maintains its coordination number of six,
the absorption spectra point to the formation of a complex with
the stoichiometry [Fe(1)2(EB]. A similar behavior was observed
for experiments with the dpa complex: addition of [Fe(dpa)2]2+ to
a solution of EB resulted in a decrease of the absorption band at
606 nm (see ESI†). However, higher concentrations of [Fe(dpa)2]2+
(~ 900 mM, 120 equiv.) were needed to achieve saturation. This
data suggest that heteroleptic Fe-dpa-EB complexes are formed
as well, but that the mixed complexes are less favored than in the
case of ligand 1.
Fig. 1 Absorption spectra of abuffered aqueous solution (MOPS, pH7.0)
containing Evans Blue (7.5 mM) upon addition of increasing amounts of
complex [Fe(1)3]5+ (0 - 22.5 mM).
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The sensing ensemble was prepared by mixing [FeCl2(H2O)4]
with the ligands dpa, 1, and EB in buffered aqueous solution
(MOPS, pH7.0).After equilibration, aliquots of stock solutions of
low molecular weight heparin (LMWH), unfractionated heparin
(UFH), dextrane sulfate, chondroitin sulfate A, chondroitin
sulfate B/dermatan sulfate, and heparan sulfate were added
(Scheme 3). The ﬁnal concentrations were: [Fe] = 30 mM, [dpa] =
300 mM, [1]= 90 mM, [EB]= 3.75 mM, and [analyte]= 25 mg ml-1.
The concentrations of the ligandswere chosen to take into account
differences in stability (dpa11b vs. the bipyridyl ligand 112) and the
absorption coefﬁcient (high value for EB). However, an extensive
optimization of the ligand concentrations was not performed.13
The samples were analyzed by UV-Vis spectroscopy after an
equilibration time of 90 min. For each analyte, six independent
analyses were performed.
Scheme 3 Experimental procedure for the sensing of sulfated
glycosaminoglycans.
Inspection of the absorption spectra showed that the analytes
had induced signiﬁcant changes in the area between 400 and
700 nm. For subsequent analyses, we focused on six different
wavelengths: 431, 545, 585, 612, 632, and 669 nm. The absolute
changes at these six wavelengths for the different analytes at a
concentration of 25 mg ml-1 are shown in Fig. 2.
Fig. 2 Response of the sensing ensemble composed of [FeCl2(H2O)4],
dpa, 1, and Evans Blue (for conc. see text) after addition of different
glycosaminoglycans (ﬁnal conc.= 25mgml-1). Blue: 431nm, green: 545nm,
yellow: 585 nm, orange: 612 nm, red: 632 nm, and purple: 669 nm. a =
LMWH, b = UFH, c = dextrane sulfate, d = chondroitin sulfate A, e =
dermatan sulfate, f = heparan sulfate. The values represent averages of six
independent measurements.
The glycosaminoglycans LMWH (Fig. 2a), UFH (Fig. 2b) and
dextrane sulfate (Fig. 2c) showed a strong interaction with the
assay mixture and therefore a very pronounced response. The ab-
sorption at 431nmdecreased,whereasmost other bands increased.
These changes indicate that a re-equilibration had occurred, which
increased the concentration of complexes containing the ligand
1 and Evans Blue on behalf of complex [Fe(dpa)2]2+ (lmax = 431
nm). The thermodynamic basis for this re-equilibration is likely the
stabilization of polycationic Fe-ligand 1 complexes by the highly
negatively charged analytes. Dextrane sulfate (Fig. 2c) displayed a
distinct change at 545 nm but relatively small changes at 612, 632,
and 669 nm compared to LMWH (Fig. 2a) and UFH (Fig. 3b).
Chondroitin sulfate A (Fig. 2d), dermatan sulfate (Fig. 2e), and
heparan sulfate (Fig. 2f) gave a lower overall response due to their
reduced charge density. Even though major changes were only
observed for 431 and 545 nm, there were also small but signiﬁcant
changes for the values at 669 nm.
Fig. 3 Score plot of a LDA performed with the sensor data at l = 431,
545, 585, 612, 632, and 669 nm. The symbols correspond to the following
samples: red = UFH, pink = LMWH, yellow = chondroitin sulfate A,
blue= dermatan sulfate, green= heparan sulfate, black= dextrane sulfate;
circles = 10 mg ml-1, triangles = 25 mg ml-1, squares = 50 mg ml-1.
Next, we have made a second sensing ensemble, in which ligand
1 was replaced by the standard 2,2-bipyridine (concentration
as described above). No signiﬁcant change in the absorption
spectrum was observed when UFH was added to this mixture
at a concentration of 25 mg ml-1. This result conﬁrmed that the
amino-substituted ligand 1 containing a positively charged side
chain was a crucial component of the sensor.
From the data shown in Fig. 3 it is apparent that a characteristic
response was obtained for each glycosaminoglycan. Analyte-
speciﬁc patterns were also found for samples containing the
glycosaminoglycans at a lower concentration of 10 mg ml-1 or
a higher concentration of 50 mg ml-1 (see ESI†). To determine
whether the variance of the data was sufﬁcient to distinguish all
samples (6 analytes ¥ 3 concentrations), we have performed a
linear discriminant analysis (LDA).14 A graphic representation of
this analysis in form of a score plot is shown in Fig. 3. Most of the
data of the different glycosaminoglycans appear in well separated
clusters. The good discrimination was conﬁrmed by “jack-knifed”
matrix validation procedure, in which one measurement at a time
was omitted. The remaining data were used as a training set and
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the omitted observation was evaluated. This procedure gave a
correct classiﬁcation in all cases. The colorimetric response of the
dynamic mixture of Fe complexes can thus be used to identify the
respective glycosaminoglycans and to obtain information about
the quantity of the analyte. It should be pointed out, however,
that we have used only three different analyte concentrations. A
more precise quantitative analysis might lead to data overlap.
Subsequently, we have explored the possibility to use the sensor
for the discrimination of mixtures of glycosaminoglycans. For
that purpose, we have examined the sensor response for samples
containing different ratios of UFH and heparan sulfate ([UFH]=
(25-x)mM, [heparan sulfate]=xmM,withx= 0, 5, 10, 15, 20, 25).
The sensing experiments were performed under similar conditions
as described above and the absorption data were evaluated by a
LDA. From the resulting score plot (Fig. 4) it is clear that all
six mixtures are clearly separated. A single UV-measurement is
thus sufﬁcient to differentiate mixtures of the glycosaminoglycans
UFH and heparan sulfate with high precision.
Fig. 4 Score plot of a LDA performed with the sensor data at l = 431,
545, 585, 612, 632, and 669 nm. The symbols correspond to the following
samples: red = pure UFH, pink = UFH/heparan sulfate 4 : 1, yellow =
UFH/heparan sulfate 3 : 2, green = UFH/heparan sulfate 2 : 3, blue =
UFH/heparan sulfate 1 : 4, black = pure heparan sulfate; [analyte]tot =
25 mg ml-1.
Conclusions
A dynamic mixture of homo- and heteroleptic iron complexes
was obtained by mixing [FeCl2(H2O)4] with the ligands dpa, 1,
and EB. When sulfated glycosaminoglycans were added to this
mixture, a re-equilibration occurred, which favored the formation
of complexes containing the ligand 1.15 The re-equilibration was
associated with a change of color. The mixture could thus be used
as a colorimetric sensor for sulfated glycosaminoglycans. The sen-
sor responsewasmost pronounced for the highly chargedLMWH,
UFH, and dextrane sulfate, but other glycosaminoglycans could
be detected as well. Each analyte gave rise to a characteristic
colorimetric response. It was therefore possible to use the UV-Vis
spectrum as a ¢ﬁngerprint¢ for the respective glycosaminoglycans.
Analysis of these color patterns by a LDA allowed to identify
glycosaminoglycans and to obtain information about the quantity
and the purity of the analytes.
The cross-reactive sensor that we have developed complements
more traditional chemosensors for glycosaminoglycans, which
are optimized for signaling the quantity of a particular analyte
(mostly heparin). The possibility to distinguish mixtures from
pure samples could be of interest for the quality control of
semi-synthetic glycosaminoglycans. With respect to potential
applications it should also be noted that minor efforts are required
for the preparation of our sensor: the synthesis of ligand 1




Dipicolylamine (Sigma), Evans Blue (Fluka), [FeCl2(H2O)4]
(Sigma), MOPS buffer (Fluka), low molecular weight hep-
arin (Fluka), unfractionated heparin (Applichem), dextran
sulfate (Sigma), heparan sulfate (Sigma), chondroitin sulfate
A (Sigma) and dermatan sulfate (Sigma) were used as re-
ceived. The ligand N-(6-aminohexyl)-4¢-methyl-2,2¢-bipyridine-4-
carboxamide hydrochlorid (1) was synthesized starting from 4,4¢-
dimethyl-bipyridin (Fluka) as described in the literature.10 Stock
solutions of the ligands and the metal salt were prepared with a
concentration of 10mM in bidistilled water. Stock solutions of the
sulfated glycosaminoglycans were prepared with a concentration
of 1 mg ml-1. MOPS buffer (100 mM, pH 7.0) was prepared with
bidistilled water and used for all experiments. All UV/Vis spectra
were recorded on a Lambda 35 spectrometer (Perkin Elmer) using
disposable cuvettes (Brand). Quartz cuvettes (Hellma) were used
for spectrophotometric titrations.
Spectrophotometric titration
A stock solution (1.0 mM) of [Fe(1)3]n+ was prepared by dissolving
the appropriate amounts of [FeCl2(H2O)4] and ligand 1 in water.
The solution was equilibrated for 24 h at room temperature before
utilization. The titration was performed by adding aliquots of
this stock solution to a buffered aqueous solution of Evans Blue
([EB] = 7.5 mM, [MOPS] = 10 mM, pH 7.0). Each aliquot
contained 0.067 equivalents of [Fe(1)3]n+ with respect to EB. After
each addition, the solution was equilibrated for 30 min at room
temperature before measuring the absorption spectra in the range
of 200 to 800 nm. Information about a similar titration with
[Fe(dpa)2]2+ can be found in the ESI.†
Sensing experiments
The sensor was prepared by mixing appropriate amounts of stock
solutions containing the ligands, the metal salt and the buffer.
After equilibration for 15 h at room temperature, a UV/Vis
spectrum was recorded. Subsequently, the analytes were added
and a second UV/Vis spectrum was recorded after equilibration
for 90 min. Each measurement was repeated six times. The ﬁnal
concentrations were: [1] = 90 mM, [dpa] = 300 mM, [Evans
Blue] = 3.75 mM, [Fe2+] = 30 mM, and [MOPS] = 10 mM. The
concentrations of the polysulfated sugars were either 10, 25, or
50 mg ml-1. For the analysis of mixtures UFH and heparan sulfate,
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the samples contained a total concentration of 25 mg ml-1. The
ratios between UHS and heparan sulfate were 4 : 1, 3 : 2, 2 : 3, and
1 : 4. For all analyses, the difference in absorption before and after
addition of the analyte at the following six wavelengths was used:
431, 545, 585, 612, 632 and 669 nm. The data were analyzed with
the commercially available statistics program SYSTAT (version
11.0) using a linear discriminant algorithm.
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